0000000000672950
AUTHOR
Kenneth Ouriel
showing 5 related works from this author
Editor's Choice – Occurrence and Classification of Proximal Type I Endoleaks After EndoVascular Aneurysm Sealing Using the Nellix™ Device
2017
Objective/Background Proximal type I endoleaks are associated with abdominal aortic aneurysm (AAA) growth and rupture and necessitate repair. The Nellix™ EndoVascular Aneurysm Sealing (EVAS) system is a unique approach to AAA repair, where the appearance and treatment of endoleaks is also different. This study aimed to analyse and categorise proximal endoleaks in an EVAS treated cohort. Methods All patients, treated from February 2013 to December 2015, in 15 experienced EVAS centres, presenting with proximal endoleak were included. Computed tomography scans were analysed by a core laboratory. A consensus meeting was organised to discuss and qualify each case for selection, technical aspects…
One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass
2019
The objective of this study was to evaluate the 1-year safety and effectiveness outcomes associated with the PQ Bypass DETOUR System (PQ Bypass, Milpitas, Calif) for the percutaneous bypass of long-segment femoropopliteal occlusive disease.This prospective, single-arm, multicenter trial enrolled patients with long-segment femoropopliteal arterial disease. The DETOUR System percutaneously deploys modular stent grafts to bypass femoropopliteal lesions through a transvenous route. Eligible patients included those with TransAtlantic Inter-Society Consensus C and D lesions100 mm in length. The primary safety end point was the major adverse event (MAE) rate through 1 month, defined as the composi…
Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System
2021
Purpose: This study investigated the 2-year safety and effectiveness of the PQ Bypass DETOUR system as a percutaneous femoropopliteal bypass. Materials and Methods: Seventy-eight patients with 82 long-segment femoropopliteal lesions were enrolled in this prospective, single-arm, multicenter study. The DETOUR system deployed Torus stent grafts directed through a transvenous route. Eligible patients included those with lesions of >10 cm and average of 371±55 mm. Key safety endpoints included major adverse events (MAEs) and symptomatic deep venous thrombosis in the target limb. Effectiveness endpoints included primary patency defined as freedom from ≥50% stenosis, occlusion, or clinically-d…
sj-docx-1-jet-10.1177_15266028211034862 – Supplemental material for Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System
2021
Supplemental material, sj-docx-1-jet-10.1177_15266028211034862 for Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System by Grzegorz Halena, Dainis K. Krievins, Dierk Scheinert, Janis Savlovskis, Piotr Szopiński, Albrecht Krämer, Kenneth Ouriel, Andrej Schmidt, Michal Zdunek and Sean P. Lyden in Journal of Endovascular Therapy
sj-docx-1-jet-10.1177_15266028211034862 – Supplemental material for Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System
2021
Supplemental material, sj-docx-1-jet-10.1177_15266028211034862 for Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System by Grzegorz Halena, Dainis K. Krievins, Dierk Scheinert, Janis Savlovskis, Piotr Szopiński, Albrecht Krämer, Kenneth Ouriel, Andrej Schmidt, Michal Zdunek and Sean P. Lyden in Journal of Endovascular Therapy